How big is the Montelukast Sodium Market?

The Montelukast Sodium Market size is expected to reach USD 4.08 billion in 2024 and grow at a CAGR of 12.60% to reach USD 7.38 billion by 2029. Read More

What is the current Montelukast Sodium Market size?

In 2024, the Montelukast Sodium Market size is expected to reach USD 4.08 billion. Read More

Who are the key players in Montelukast Sodium Market?

Merck & Co., Inc., Morepen Laboratories, Teva Pharmaceuticals USA, Inc., Cipla Limited and Sanofi Aventis are the major companies operating in the Montelukast Sodium Market. Read More

Which is the fastest growing region in Montelukast Sodium Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Montelukast Sodium Market?

In 2024, the North America accounts for the largest market share in Montelukast Sodium Market. Read More

What years does this Montelukast Sodium Market cover, and what was the market size in 2023?

In 2023, the Montelukast Sodium Market size was estimated at USD 3.62 billion. The report covers the Montelukast Sodium Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Montelukast Sodium Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Montelukast Sodium Market Size & Share Analysis - Industry Research Report

Montelukast Sodium Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Montelukast Sodium Market is Segmented by Dosage Form (Tablets, and Oral Solutions), Application (Asthma, Allergic Rhinitis, Urticaria, and Other Applications), and Geography (North America, Europe, Asia-Pacific, and Rest of the World). The report offers the value (in USD million) for the above segments.

Montelukast Sodium Industry Overview

The montelukast sodium market is moderately competitive and consists of several major players. Some of the companies that are currently dominating the market are Merck & Co. Inc., Morepen Laboratories, Teva Pharmaceuticals USA Inc., Mylan NV, Cipla Limited, Intas Pharmaceuticals Ltd, Sun Pharma, Apotex Inc, Sanyo Chemical Industries Ltd, and Delmar Chemicals Inc.